GSA Capital Partners’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-17,468
Closed -$152K 2039
2023
Q1
$152K Sell
17,468
-48,861
-74% -$391K 0.02% 1304
2022
Q4
$416K Sell
66,329
-32,700
-33% -$124K 0.05% 715
2022
Q3
$347K Buy
99,029
+36,835
+59% +$132K 0.05% 830
2022
Q2
$183K Sell
62,194
-130,050
-68% -$311K 0.03% 1094
2022
Q1
$598K Sell
192,244
-38,014
-17% -$120K 0.08% 426
2021
Q4
$778K Sell
230,258
-33,966
-13% -$129K 0.1% 329
2021
Q3
$964K Buy
264,224
+133,552
+102% +$526K 0.1% 325
2021
Q2
$570K Sell
130,672
-55,645
-30% -$247K 0.06% 547
2021
Q1
$846K Buy
186,317
+33,520
+22% +$180K 0.14% 167
2020
Q4
$877K Buy
+152,797
New +$1.16M 0.14% 170
2020
Q1
Sell
-197,290
Closed -$387K 1669
2019
Q4
$387K Buy
197,290
+151,187
+328% +$568K 0.05% 839
2019
Q3
$236K Buy
46,103
+3,818
+9% +$23.1K 0.03% 1086
2019
Q2
$303K Buy
+42,285
New +$479K 0.03% 997
2018
Q4
Sell
-62,500
Closed -$693K 1827
2018
Q3
$693K Buy
+62,500
New +$776K 0.04% 911
2018
Q1
Sell
-66,200
Closed -$609K 1875
2017
Q4
$609K Sell
66,200
-84,900
-56% -$726K 0.04% 844
2017
Q3
$1.22M Buy
+151,100
New +$1.02M 0.08% 389

Other funds holding CBAY